Literature DB >> 8398586

Ginkgo biloba extract and cognitive decline.

D M Warburton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8398586      PMCID： PMC1364581          DOI： 10.1111/j.1365-2125.1993.tb04213.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  8 in total

Review 1.  Pharmacotherapy of cognitive deficits in Alzheimer's disease and age-associated memory impairment.

Authors:  T Crook
Journal:  Psychopharmacol Bull       Date:  1988

2.  The aging process.

Authors:  D Harman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

Review 3.  Oxygen free radicals and brain dysfunction.

Authors:  J A Jesberger; J S Richardson
Journal:  Int J Neurosci       Date:  1991-03       Impact factor: 2.292

Review 4.  Ginkgo biloba for cerebral insufficiency.

Authors:  J Kleijnen; P Knipschild
Journal:  Br J Clin Pharmacol       Date:  1992-10       Impact factor: 4.335

5.  Flavonoids are scavengers of superoxide anions.

Authors:  J Robak; R J Gryglewski
Journal:  Biochem Pharmacol       Date:  1988-03-01       Impact factor: 5.858

6.  Changes in nerve cells of the nucleus basalis of Meynert in Alzheimer's disease and their relationship to ageing and to the accumulation of lipofuscin pigment.

Authors:  D M Mann; P O Yates; B Marcyniuk
Journal:  Mech Ageing Dev       Date:  1984 Apr-May       Impact factor: 5.432

Review 7.  [Clinical psychopharmacology of Ginkgo biloba extract].

Authors:  D M Warburton
Journal:  Presse Med       Date:  1986-09-25       Impact factor: 1.228

8.  [Antiradical properties of Ginkgo biloba extract].

Authors:  J Pincemail; C Deby
Journal:  Presse Med       Date:  1986-09-25       Impact factor: 1.228
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.